Biopharma Biz Medincell Raises €43M In Global Offering
Medincell SA, a pharmaceutical technology business, said Wednesday it has raised €42.9 million ($45 million) through issuing shares to investors, as it looks to expand its technology and strengthen its balance...To view the full article, register now.
Already a subscriber? Click here to view full article